These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

779 related items for PubMed ID: 18692357

  • 21. A Comparative Cost-Effectiveness Analysis of Percutaneous Transluminal Angioplasty With Optional Stenting and Femoropopliteal Bypass Surgery for Medium-Length TASC II B and C Femoropopliteal Lesions.
    Vossen RJ, Philipszoon PC, Vahl AC, Montauban van Swijndregt AD, Leijdekkers VJ, Balm R.
    J Endovasc Ther; 2019 Apr; 26(2):172-180. PubMed ID: 30898070
    [Abstract] [Full Text] [Related]

  • 22. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft.
    Farraj N, Srivastava A, Pershad A.
    J Invasive Cardiol; 2009 Jun; 21(6):278-81. PubMed ID: 19494404
    [Abstract] [Full Text] [Related]

  • 23. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
    Schmieder GC, Richardson AI, Scott EC, Stokes GK, Meier GH, Panneton JM.
    J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Benign superior vena cava syndrome: stenting is now the first line of treatment.
    Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P.
    J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
    [Abstract] [Full Text] [Related]

  • 28. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
    Canaud L, Alric P, Berthet JP, Marty-Ané C, Mercier G, Branchereau P.
    J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
    [Abstract] [Full Text] [Related]

  • 29. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up.
    Nishibe T, Kondo Y, Dardik A, Muto A, Koizumi J, Nishibe M.
    J Cardiovasc Surg (Torino); 2009 Aug; 50(4):493-9. PubMed ID: 19734834
    [Abstract] [Full Text] [Related]

  • 30. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E, Beschorner U.
    J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
    [Abstract] [Full Text] [Related]

  • 31. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery.
    Kudo T, Chandra FA, Kwun WH, Haas BT, Ahn SS.
    J Vasc Surg; 2006 Aug; 44(2):304-13. PubMed ID: 16890859
    [Abstract] [Full Text] [Related]

  • 32. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
    Conrad MF, Cambria RP, Stone DH, Brewster DC, Kwolek CJ, Watkins MT, Chung TK, LaMuraglia GM.
    J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
    [Abstract] [Full Text] [Related]

  • 33. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
    Schneider JR, Verta MJ, Alonzo MJ, Hahn D, Patel NH, Kim S.
    Vasc Endovascular Surg; 2011 Jul; 45(5):391-7. PubMed ID: 21669863
    [Abstract] [Full Text] [Related]

  • 34. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E, Marks NA, Hingorani AP, Schutzer RW, Mutyala M.
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [Abstract] [Full Text] [Related]

  • 35. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice.
    Donas KP, Schwindt A, Schönefeld T, Tessarek J, Torsello G.
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):688-93. PubMed ID: 19328021
    [Abstract] [Full Text] [Related]

  • 36. Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes.
    Robinson WP, Nguyen LL, Bafford R, Belkin M.
    J Vasc Surg; 2011 Mar; 53(3):651-7. PubMed ID: 21129908
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of Long-Term Outcomes of Femoropopliteal Bypass Surgery in Patients With Chronic Limb-Threatening Ischemia in an Endovascular Era.
    Betz T, Ingolf T, Markus S, Florian Z, Christian U.
    Ann Vasc Surg; 2022 Feb; 79():191-200. PubMed ID: 34644653
    [Abstract] [Full Text] [Related]

  • 38. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
    Baril DT, Marone LK, Kim J, Go MR, Chaer RA, Rhee RY.
    J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
    [Abstract] [Full Text] [Related]

  • 39. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia.
    Todd KE, Ahanchi SS, Maurer CA, Kim JH, Chipman CR, Panneton JM.
    J Vasc Surg; 2013 Oct; 58(4):941-8. PubMed ID: 23755978
    [Abstract] [Full Text] [Related]

  • 40. Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: medium-term results of a randomized controlled trial (the REVAS trial).
    Gisbertz SS, Tutein Nolthenius RP, de Borst GJ, van der Laan L, Overtoom TT, Moll FL, de Vries JP.
    Ann Vasc Surg; 2010 Nov; 24(8):1015-23. PubMed ID: 21035693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.